Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Filings indexed 2,023 across all filing types
Latest filing 2021-08-02 Transaction in Own Shar…
Country BE Belgium
Listing BR UCB

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
ENG.pdf
Transaction in Own Shares Classification · 99% confidence The document is explicitly titled "Disposals of own shares" and details transactions where the company disposed of its own shares OTC following stock option exercises for personnel under various Long Term Incentive (LTI) Plans. This directly corresponds to the definition of a report concerning the company buying back or selling its own shares (share repurchase/issuance). The appropriate code is POS (Transaction in Own Shares). The document is a direct announcement of the transaction, not an announcement of a report, so RPA/RNS is not applicable.
2021-08-02 English
FR.pdf
Transaction in Own Shares Classification · 99% confidence The document title is "Aliénation d'actions propres" (Disposal of own shares) and the text explicitly states that UCB SA is making public the alienation (disposal/sale) of its own shares following option exercises by staff members. This directly corresponds to the definition of 'Transaction in Own Shares' (share repurchase/issuance). The filing code POS matches this activity. The document is short and appears to be a regulatory disclosure of a specific transaction type, not a general announcement of a report (RPA) or a broad regulatory filing (RNS).
2021-08-02 French
NL.pdf
Transaction in Own Shares Classification · 99% confidence The document is titled "Vervreemding van eigen aandelen" (Disposal of own shares) and details transactions where UCB shares were delivered to employees exercising stock options under Long-Term Incentive (LTI) plans. This activity—the company dealing in its own shares, specifically related to employee stock plans—directly corresponds to the definition of 'Transaction in Own Shares'. The code for this is POS. The document is a formal announcement (gereglementeerde informatie) detailing specific transactions, not just an announcement that a report is forthcoming (which would suggest RPA or RNS).
2021-08-02 Dutch
2021 HY report - final_29-07-21 - ENG (1).pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled '2021 Half-Year Financial Report' and covers the period ended 30 June 2021. It contains comprehensive financial statements, including the income statement, statement of financial position, cash flow statement, and notes to the consolidated financial statements. It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2021
2021-07-29 English
2021 HY report - final_29-07-21 - FR.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Rapport de gestion du premier semestre 2021' (Management Report for the first half of 2021) and contains comprehensive financial statements, including consolidated income statements, balance sheets, cash flow statements, and detailed notes to the financial statements for the period ending June 30, 2021. It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2021
2021-07-29 French
2021 HY report - final_29-07-21 - NL.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Halfjaarlijks Financieel Verslag 2021' (Half-Yearly Financial Report 2021) for the period ending June 30, 2021. It contains comprehensive financial statements, including consolidated balance sheets, income statements, cash flow statements, and detailed management commentary on performance. It is not an announcement or a summary, but the full interim report itself. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2021
2021-07-29 Dutch

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.